Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
05/16/2007 | EP1434485B1 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives for use as pesticides |
05/16/2007 | EP1306373B1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
05/16/2007 | CN1964970A Iap的抑制剂 Iap inhibitors |
05/16/2007 | CN1964965A Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
05/16/2007 | CN1964952A Pyridazin-3(2h)-one derivatives and their use as PDE4 inhibitors |
05/16/2007 | CN1964950A Propane-1,3-dione derivative or its salt |
05/16/2007 | CN1964948A Therapeutic agents |
05/16/2007 | CN1964946A 2-propylene-1-ones as hsp70 inducer |
05/16/2007 | CN1964944A Indole derivatives as antiviral agents |
05/16/2007 | CN1962641A Metalloproteinase inhibitors |
05/16/2007 | CN1315824C R- - -1- [2- 7-chlorobenzo [b] thiophen-3 -yl- methoxy -2- 2,4-dichlorophenyl -ethyl] -1h-imidazole |
05/16/2007 | CN1315820C Thiophene carboxamides as inhibitors of the enzyme IKK-2 |
05/16/2007 | CN1315806C Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
05/15/2007 | US7217826 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
05/15/2007 | US7217823 4,4-Disubstituted piperidines, and methods of use thereof |
05/15/2007 | US7217728 For therapy of reperfusion injury |
05/15/2007 | US7217716 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate NR2B antagonists |
05/15/2007 | CA2148612C 2-fluoroalkyl-substituted benzimidazoles, their preparation and their use as pesticides |
05/10/2007 | WO2007053776A1 Pyrimidinyl-thiophene kinase modulators |
05/10/2007 | WO2007053765A2 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase |
05/10/2007 | WO2007053662A1 Dihydroisoindolones as allosteric modulators of glucokinase |
05/10/2007 | WO2007053657A1 Substituted pyrrolones as allosteric modulators of glucokinase |
05/10/2007 | WO2007053498A1 Compounds useful as antagonists of ccr2 |
05/10/2007 | WO2007053131A2 Acrylamide derivatives as antibiotic agents |
05/10/2007 | WO2007052843A1 Heterocyclic amide compound and use thereof |
05/10/2007 | WO2007052808A1 Hydrazide compound and thrombopoietin receptor activator |
05/10/2007 | WO2007052073A2 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors |
05/10/2007 | WO2007030574A3 1 , 4 and 1 , 5-disubstituted indole derivatives for use as ppar active compounds |
05/10/2007 | WO2007007282A3 Azabicyclo derivatives as muscarinic receptor antagonists |
05/10/2007 | WO2007002701A3 Anti-inflammatory aryl nitrile compounds |
05/10/2007 | US20070106081 Bicyclic derivatives as ppar modulators |
05/10/2007 | US20070106075 Triazine based photoactive compound containing oxime ester |
05/10/2007 | US20070105943 Novel antifungal agent containing heterocyclic compound |
05/10/2007 | US20070105929 2, 4, 5 - Trisubstituted Imidazoles And Their Use As Anti-Microbial Agents |
05/10/2007 | US20070105913 Alkynyl aryl carboxamides |
05/10/2007 | US20070105906 N-(1-{3-[(R)-2-[3-(phenylsulphonylamino)-phenyl]-2-hydroxy-ethylamino]-3-methyl-butyl}-1H-indol-5-yl)-2-cyano-acetamide, used for treating non-insulin dependent diabetes, obesity or overactive bladder |
05/10/2007 | US20070105905 Novel macrocycles for the treatment of cancer |
05/10/2007 | US20070105899 Benzene compounds |
05/10/2007 | US20070105881 For improving perception, concentration, learning or memory; 2-(Cyclopentylmethyl)-4-[(fluorophenyl)amino]6-oxo-1,6-dihydro-5-pyrimidinecarbonitrile; amination of methyl 2-cyano propenoate derivatives, cyclization using amidinehydrochloride derivatives |
05/10/2007 | US20070105871 1,3,4-Substituted pyrazoles as 5-ht receptor antagonists for the treatment of psychoses and neurological disorders |
05/10/2007 | US20070105860 Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors |
05/10/2007 | US20070105858 Retinoic acid mimetic anilides |
05/10/2007 | US20070105855 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
05/10/2007 | US20070105854 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
05/10/2007 | US20070105852 Thiophene and furan compounds |
05/10/2007 | US20070105845 Quinolone derivatives |
05/10/2007 | US20070105838 Bicyclic Benzamide Compoundssa as Histamine H3 Receptor Ligand Useful in the Treatment of Neurological Diseases |
05/10/2007 | US20070105834 histamine H3 receptor modulators; obesity, diabetes and central nervous system diseases such as vigilance and sleep disorders; e.g. (+)-2-(cyclohexylmethyl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl] -1,2,3 ,4-tetrahydroisoquinoline-7-sulfonamide |
05/10/2007 | US20070103060 Platinum complex and light emitting device |
05/10/2007 | CA2628474A1 Pyrimidinyl-thiophene kinase modulators |
05/10/2007 | CA2628259A1 Dihydroisoindolones as allosteric modulators of glucokinase |
05/10/2007 | CA2627910A1 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase |
05/10/2007 | CA2627813A1 Substituted pyrrolones as allosteric modulators of glucokinase |
05/10/2007 | CA2627423A1 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors |
05/09/2007 | EP1783124A1 2-phenylthiophene derivative |
05/09/2007 | EP1783116A1 2-phenylpyridine derivative |
05/09/2007 | EP1782811A1 Novel antimalaria agent containing heterocyclic compound |
05/09/2007 | EP1781639A1 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
05/09/2007 | EP1781638A2 Imidazolo-related compounds, compositions and methods for their use |
05/09/2007 | EP1781636A1 Pyrrole derivatives, their preparation and their therapeutic use |
05/09/2007 | EP1781633A1 Novel antidiabetic compounds |
05/09/2007 | EP1781623A1 Compounds and compositions useful as cathepsin s inhibitors |
05/09/2007 | EP1781621A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
05/09/2007 | EP1781620A1 Novel beta agonists, method for producing the same and their use as drugs |
05/09/2007 | EP1680418B1 Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
05/09/2007 | EP1654229B1 Piperidine derivatives as ccr5 receptor modulators |
05/09/2007 | EP1572667B1 Cathepsin cysteine protease inhibitors and their use in the treatment of inflammation and immune disorders |
05/09/2007 | EP1501796B1 3-(pyridinyl-amino)-1h-indole-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
05/09/2007 | EP1238970B9 Cycloamine ccr5 receptor antagonists |
05/09/2007 | EP1191931B1 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
05/09/2007 | EP1183245B1 Selective npy (y5) antagonists |
05/09/2007 | CN1960985A Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors |
05/09/2007 | CN1960976A 4-carbox pyrazole derivates useful as anti-viral agents |
05/09/2007 | CN1960975A Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP) |
05/09/2007 | CN1960971A Substituted pyrrolidine-2-ones |
05/09/2007 | CN1960970A Pyrrolidine derivatives as CB1-receptor antagonists |
05/09/2007 | CN1960726A Composition comprising a jnk inhibitor and cyclosporin |
05/09/2007 | CN1314684C Synthesis method of saijiabin, its racemate and S-configuration, and preparation method of its amorphous powder |
05/09/2007 | CN1314681C 2,3-diazanaphthalene derivatives with angiogenesis inhibiting activity |
05/08/2007 | US7214800 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents |
05/08/2007 | US7214698 Beta-agonists, processes for preparing them and their use as pharmaceutical compositions |
05/08/2007 | US7214687 Quinuclidine derivatives and medicinal compositions containing the same |
05/08/2007 | US7214681 Tri(cyclo) substituted amide compounds |
05/08/2007 | US7214678 Having antiinflammatory, anti-pyretic and anti-diarrheal properties |
05/08/2007 | US7214677 Benzamide, heteroarylamide and reverse amides |
05/08/2007 | CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
05/08/2007 | CA2275479C Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
05/03/2007 | WO2007050721A2 Heterocyclic aspartyl protease inhibitors |
05/03/2007 | WO2007049813A1 BENZO[b]THIOPHEN DERIVATIVE AND PROCESS FOR PRODUCTION THEREOF |
05/03/2007 | WO2007049812A1 3-HYDROXYMETHYLBENZO[b]THIOPHENE DERIVATIVE AND METHOD FOR PRODUCING SAME |
05/03/2007 | WO2007048788A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
05/03/2007 | WO2007048779A1 Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists |
05/03/2007 | WO2007022947A3 5-ring heteroaromatic compounds and their use as binding partners for 5-ht5 receptors |
05/03/2007 | WO2007011626A3 Histone deacetylase inhibitors |
05/03/2007 | WO2006111560A3 2,3 substituted pyrazine sulfonamides as inhibitors of crth2 |
05/03/2007 | US20070100147 Process for preparing raloxifene hydrochloride |
05/03/2007 | US20070099991 Selective rxr ligands |
05/03/2007 | US20070099985 Heteroaromate OSC inhibitors |
05/03/2007 | US20070099955 3-piperidinylisochroman-5-ols as dopamine agonists |
05/03/2007 | US20070099944 ROCK-1 kinase and/or Aurora kinase inhibitors; indazolo-tetrahydropyrimidine-carboxamide derivatives; 4-(4-fluorophenyl)-N-1H-indazol-5-yl-6-methyl-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxamide; antiinflammatory, antidiabetic, antiproliferative agents |